Immune to Cancer: The CRI Blog
-
ASCO19 Recap: Caring for Every Patient, Learning from Every Patient
ASCO19 highlighted a number of immunotherapy developments, including those relating to long-term survival, introducing immunotherapy earlier, biomarkers,…
-
ASCO19 Day 5 Update: CAR T Cells for Pleural Cancers and More Melanoma News
The final day of ASCO19 covered CAR T cells for pleural cancers and long-term updates on several…
-
Dr. Robert Schreiber and Interferon Gamma
By redefining our understanding of the relationship between cancer and the immune system, Dr. Robert Schreiber has…
-
AACR19 Day 3 Update: CAR T Cells, Vaccines, and Hope Against Pancreatic Cancer
In addition to advances involving CAR T cell therapy and vaccines, a CRI-funded trial revealed the promise…
-
IO360 2019 Preview: Collaboration, Investment, Clinical Trials, and Combinations
The fifth annual Immuno-Oncology 360° conference will be held on February 6-8, 2019 in New York City.
-
ASH18 Preview: Blood Cancer Immunotherapy Developments at 60th American Society of Hematology Meeting
The 2018 American Society of Hematology meeting will showcase a variety of basic and clinical advances in…
-
CICON18 Day 4 Update: The Role of Bacteria; Technologies to Advance Cancer Immunotherapy
The final day of CICON18 explored two diverse areas—technology and the microbiome—that both have the…
-
ASCO18 Update: Enhancing the Immune System’s Power Through Combination Therapies
Day 2 of ASCO18 highlighted a number of combinations and novel agents that aimed to improve immunotherapy’s…
-
ASCO18 Update: Vaccines, CAR T Cells, and OX40 Checkpoint Therapy
The first day of ASCO18 highlighted diverse immunotherapies, including vaccines, CAR T cells, and novel checkpoint drugs